Hi synaphai, you said “So I think our large upcoming US pivotal trial will likely will serve both a US and Canada approval”. My post was more towards ViV, and I am thinking if a separate ViV study in Canada may bring to a quicker commercialisation approval of DurAVR in Canada. I recalled you might have mentioned a separate ViV trial maybe needed for FDA clearance?
Not advice and DYOR
AVR Price at posting:
$16.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)